Should I buy Assurant (AIZ) stock or is it too late?
⭐ The most reliable of them, either direction: Truist Securities — 77% of its targets hit on this sector (133 calls tested). It aims for $355 (+31 %), call made on August 7, 2026, maturing on August 7, 2027 (68 d ago).
Firm-by-firm track record on Assurant
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Keefe, Bruyette & Woods | 100 % | +24.2 % | 6 | $325 +20% |
| Piper Sandler | 88 % | +18.1 % | 8 | $329 +21% |
| Truist Securities | 100 % | +15.0 % | 5 | $355 +31% |
| Morgan Stanley | 74 % | +11.0 % | 19 | $300 +11% |
| UBS | 71 % | +8.8 % | 14 | $331 +22% |
| B of A Securities | 70 % | +1.0 % | 10 | $233 -14% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 6 ratings) — a sign of market conviction.
- Median price target $327, i.e. +21% from the current price ($271).
- The most reliable firm on AIZ, Keefe, Bruyette & Woods (100% hit rate, 6 scored calls), targets $325 (call made on August 7, 2026, maturing on August 7, 2027) (+20%) in its most recent call, and $254 (call made on November 20, 2025, maturing on November 20, 2026) (-6%) in the one coming due soonest.
- 6 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Reasonable valuation (P/E ~13) relative to its sector.
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on AIZ
Median target $327 (+21%) · 6 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Assurant now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $327 (+21%), and Keefe, Bruyette & Woods (most reliable on AIZ, 100%) targets $325. Weigh that against valuation (P/E ~13). This is not personalized advice.
Is it too late to invest in Assurant?
Not according to analysts: the median target ($327) is still +21% above the current price ($271) (most reliable on AIZ: Keefe, Bruyette & Woods, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Assurant still worth investing in?
It depends on the gap between the price ($271) and its estimated value: analysts target $327 on median (+21%), with 100% buys (most reliable on AIZ: Keefe, Bruyette & Woods, 100%). Cross-check with their real reliability on AIZ and the cautions above. Information, not advice.
What's the main risk in buying AIZ?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full Assurant profile (consensus, analyst reliability, price target, performance).